Livzon Pharmaceutical Group Inc Cash Flow Conversion Efficiency

Latest as of December 2025: 0.040x

Livzon Pharmaceutical Group Inc cash flow conversion efficiency. Based on the latest financial reports, Livzon Pharmaceutical Group Inc (000513) has a cash flow conversion efficiency ratio of 0.040x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥625.70 Million ≈ $91.56 Million USD) by net assets (CN¥15.79 Billion ≈ $2.31 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Livzon Pharmaceutical Group Inc stock valuation for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Livzon Pharmaceutical Group Inc (1998–2025)

Cash flow conversion efficiency of Livzon Pharmaceutical Group Inc from 1998 to 2025. This chart illustrates how Livzon Pharmaceutical Group Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 000513 share price today for real-time trading data and today's change.

Livzon Pharmaceutical Group Inc Cash Flow Conversion Ratio Explained

Livzon Pharmaceutical Group Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Livzon Pharmaceutical Group Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Livzon Pharmaceutical Group Inc ranked by their cash flow conversion efficiency. Review cash generation quality of Livzon Pharmaceutical Group Inc to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
TAG Immobilien AG F:TEG	0.040x
Benchmark Electronics Inc NYSE:BHE	0.031x
Greif Inc NYSE:GEF-B	0.038x
Shanghai Beite Technology Co SHG:603009	0.030x
DB HiTek Co Ltd KO:000990	0.037x
Select Energy Services Inc NYSE:WTTR	0.009x
By health SHE:300146	0.025x
Shufersal TA:SAE	0.022x

Annual Cash Flow Conversion Efficiency for Livzon Pharmaceutical Group Inc (1998–2025)

The table below shows the annual cash flow conversion efficiency of Livzon Pharmaceutical Group Inc from 1998 to 2025. Also see balance sheet size of Livzon Pharmaceutical Group Inc for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥15.79 Billion ≈ $2.31 Billion	CN¥3.18 Billion ≈ $465.18 Million	0.201x	+0.75%
2024-12-31	CN¥14.91 Billion ≈ $2.18 Billion	CN¥2.98 Billion ≈ $435.90 Million	0.200x	-9.17%
2023-12-31	CN¥14.77 Billion ≈ $2.16 Billion	CN¥3.25 Billion ≈ $475.42 Million	0.220x	+18.52%
2022-12-31	CN¥14.94 Billion ≈ $2.19 Billion	CN¥2.77 Billion ≈ $405.73 Million	0.186x	+39.65%
2021-12-31	CN¥14.31 Billion ≈ $2.09 Billion	CN¥1.90 Billion ≈ $278.37 Million	0.133x	-16.09%
2020-12-31	CN¥13.64 Billion ≈ $2.00 Billion	CN¥2.16 Billion ≈ $316.19 Million	0.158x	+10.04%
2019-12-31	CN¥12.28 Billion ≈ $1.80 Billion	CN¥1.77 Billion ≈ $258.59 Million	0.144x	+33.44%
2018-12-31	CN¥11.75 Billion ≈ $1.72 Billion	CN¥1.27 Billion ≈ $185.49 Million	0.108x	-7.90%
2017-12-31	CN¥11.23 Billion ≈ $1.64 Billion	CN¥1.32 Billion ≈ $192.55 Million	0.117x	-34.93%
2016-12-31	CN¥7.11 Billion ≈ $1.04 Billion	CN¥1.28 Billion ≈ $187.19 Million	0.180x	-6.67%
2015-12-31	CN¥4.81 Billion ≈ $703.84 Million	CN¥927.79 Million ≈ $135.76 Million	0.193x	+9.77%
2014-12-31	CN¥4.08 Billion ≈ $597.39 Million	CN¥717.39 Million ≈ $104.98 Million	0.176x	+43.96%
2013-12-31	CN¥3.60 Billion ≈ $527.45 Million	CN¥439.99 Million ≈ $64.38 Million	0.122x	-34.65%
2012-12-31	CN¥3.18 Billion ≈ $465.35 Million	CN¥593.96 Million ≈ $86.92 Million	0.187x	-20.57%
2011-12-31	CN¥3.01 Billion ≈ $440.69 Million	CN¥708.20 Million ≈ $103.63 Million	0.235x	-2.00%
2010-12-31	CN¥2.64 Billion ≈ $386.19 Million	CN¥633.30 Million ≈ $92.67 Million	0.240x	+7.91%
2009-12-31	CN¥2.23 Billion ≈ $325.65 Million	CN¥494.88 Million ≈ $72.42 Million	0.222x	+18.18%
2008-12-31	CN¥1.83 Billion ≈ $268.45 Million	CN¥345.18 Million ≈ $50.51 Million	0.188x	+50.71%
2007-12-31	CN¥1.99 Billion ≈ $291.33 Million	CN¥248.55 Million ≈ $36.37 Million	0.125x	-20.69%
2006-12-31	CN¥1.44 Billion ≈ $210.51 Million	CN¥226.46 Million ≈ $33.14 Million	0.157x	+21.03%
2005-12-31	CN¥1.24 Billion ≈ $181.22 Million	CN¥161.07 Million ≈ $23.57 Million	0.130x	-16.00%
2004-12-31	CN¥1.17 Billion ≈ $171.49 Million	CN¥181.46 Million ≈ $26.55 Million	0.155x	-39.38%
2003-12-31	CN¥1.17 Billion ≈ $171.87 Million	CN¥300.01 Million ≈ $43.90 Million	0.255x	+35.12%
2002-12-31	CN¥1.13 Billion ≈ $165.38 Million	CN¥213.65 Million ≈ $31.26 Million	0.189x	+25.81%
2001-12-31	CN¥1.03 Billion ≈ $151.09 Million	CN¥155.15 Million ≈ $22.70 Million	0.150x	+277.27%
2000-12-31	CN¥967.05 Million ≈ $141.51 Million	CN¥38.52 Million ≈ $5.64 Million	0.040x	-84.25%
1999-12-31	CN¥973.90 Million ≈ $142.51 Million	CN¥246.23 Million ≈ $36.03 Million	0.253x	+1449.54%
1998-12-31	CN¥972.07 Million ≈ $142.24 Million	CN¥-18.21 Million ≈ $-2.66 Million	-0.019x	--

About Livzon Pharmaceutical Group Inc

SHE:000513 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.45 Billion

CN¥16.77 Billion CNY

Market Cap Rank

#5286 Global

#861 in China

Share Price

CN¥28.52

Change (1 day)

+3.18%

52-Week Range

CN¥25.97 - CN¥37.60

All Time High

CN¥1418.81